Toxins, 2018 · DOI: 10.3390/toxins10030128 · Published: March 18, 2018
This study investigates the effects of botulinum toxin B (BoNT/B) on neuropathic pain and functional recovery in mice with sciatic nerve injury, comparing it to botulinum toxin A (BoNT/A). The research explores whether BoNT/B can alleviate pain and promote nerve regeneration and functional recovery, similar to BoNT/A. The study found that BoNT/B effectively reduces neuropathic pain over a long period, similar to BoNT/A. However, unlike BoNT/A, BoNT/B did not improve functional recovery, suggesting a difference in how these toxins affect the recovery process after nerve injury. The researchers also examined the impact of BoNT/B on glial cells in the spinal cord and observed that it reduced activation of astrocytes in the dorsal horn. This finding suggests a potential mechanism through which BoNT/B alleviates pain by affecting the central nervous system's pain processing.
While both BoNT/A and BoNT/B can be used as analgesics, BoNT/A may be preferred when aiming to accelerate functional recovery of the injured limb.
Further research is needed to clarify the molecular mechanisms underlying the differential effects of BoNT/A and BoNT/B in neuropathic pain.
The findings highlight that BoNT/A and BoNT/B are not fully interchangeable in therapeutic approaches for neuropathic pain induced by peripheral nerve injury.